[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652056":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":40,"centralContacts":27,"locations":52,"responsibleParty":453,"collaborators":455,"id":458,"slug":459,"hasResults":460,"nctId":461,"briefTitle":462,"officialTitle":463,"acronym":464,"eligibilityCriteria":465,"healthyVolunteers":460,"sex":466,"minAge":467,"maxAge":27,"enrollmentInfo":468,"targetDuration":27,"studyType":471,"phases":472,"briefSummary":474,"conditions":475,"keywords":477,"overallStatus":484,"whyStopped":27,"lastUpdateSubmitDate":485,"lastUpdatePostDateStruct":486,"startDateStruct":489,"completionDateStruct":491,"leadSponsor":493,"locationsCount":494},{"fullName":5,"class":6},"Corbus Pharmaceuticals Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"CRB-701","EXPERIMENTAL","3.6mg\u002FKg CRB-701 administered intravenously Q3W.",[13],"Drug: CRB-701",{"label":15,"type":16,"description":17,"interventionNames":18},"Investigator's Choice monotherapy","ACTIVE_COMPARATOR","Investigator's choice of capcitabine, cetuximab or docetaxel",[19,20,21],"Drug: capcitabine","Drug: Cetuximab (EGFR inhibitor)","Drug: Docetaxel",[23,28,32,36],{"type":24,"name":9,"description":25,"armGroupLabels":26,"otherNames":27},"DRUG","CRB-701 3.6mg\u002FKg administered intravenously every 21 days (Q3W)",[9],null,{"type":24,"name":29,"description":30,"armGroupLabels":31,"otherNames":27},"capcitabine","1250 mg\u002Fm2 twice daily on days 1-14 of each 21-day cycle",[15],{"type":24,"name":33,"description":34,"armGroupLabels":35,"otherNames":27},"Cetuximab (EGFR inhibitor)","400mg\u002Fm2 loading dose followed by 250mg\u002Fm2 weekly as an IV infusion or 500mg\u002Fm2 every 2 weeks.",[15],{"type":24,"name":37,"description":38,"armGroupLabels":39,"otherNames":27},"Docetaxel","75 mg\u002Fm2 as an IV infusion on day 1 of each 21-day cycle or 30 mg\u002Fm2 weekly to escalate to 40 mg\u002Fm2, if tolerated.",[15],[41,45,48],{"name":42,"affiliation":43,"role":44},"Cesar Peres, MD","Florida Cancer Specialists and Research Institute and Sarah Cannon Research Institute","PRINCIPAL_INVESTIGATOR",{"name":46,"affiliation":47,"role":44},"Pablo Nenclares, MD","Barts & The London NHS Trust",{"name":49,"affiliation":50,"role":51},"Ari Rosenberg, MD","University of Chicago","STUDY_CHAIR",[53,74,91,105,119,133,148,161,173,188,202,215,230,246,261,276,291,306,320,335,350,361,376,390,405,419,436],{"facility":54,"status":27,"city":55,"state":56,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"The University of Arizona Cancer Center","Tucson","Arizona","85719","United States","US",{"type":61,"coordinates":62},"Point",[63,64],-110.92648,32.22174,{"lat":64,"lon":63},[67,72],{"name":68,"role":69,"phone":70,"phoneExt":27,"email":71},"Clinical Study Coordinator","CONTACT","+1-(520)-654-2873","UACC-Clinicaltrialsinfo@arizona.edu",{"name":73,"role":44,"phone":27,"phoneExt":27,"email":27},"Ricklie Julian",{"facility":75,"status":27,"city":76,"state":77,"zip":78,"country":58,"countryCode":59,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"City of Hope Comprehensive Cancer Center","Duarte","California","91010",{"type":61,"coordinates":80},[81,82],-117.97729,34.13945,{"lat":82,"lon":81},[85,89],{"name":86,"role":69,"phone":87,"phoneExt":27,"email":88},"Study Coordinator","+1 (877)-405-2009","clinical@corbuspharma.com",{"name":90,"role":44,"phone":27,"phoneExt":27,"email":27},"Aditya Shreenivas, MD",{"facility":92,"status":27,"city":93,"state":77,"zip":94,"country":58,"countryCode":59,"cosmosGeoPoint":95,"geoPoint":99,"contacts":100},"University of California Los Angeles Westwood Cancer Center","Los Angeles","90095",{"type":61,"coordinates":96},[97,98],-118.24368,34.05223,{"lat":98,"lon":97},[101,103],{"name":68,"role":69,"phone":102,"phoneExt":27,"email":88},"+1-(310)-794-4955",{"name":104,"role":44,"phone":27,"phoneExt":27,"email":27},"Deborah Wong",{"facility":106,"status":27,"city":107,"state":77,"zip":108,"country":58,"countryCode":59,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"Stanford Medicine - Cancer Center","Palo Alto","94304",{"type":61,"coordinates":110},[111,112],-122.14302,37.44188,{"lat":112,"lon":111},[115,117],{"name":68,"role":69,"phone":116,"phoneExt":27,"email":27},"+1-(833)-444-7622",{"name":118,"role":44,"phone":27,"phoneExt":27,"email":27},"Hyunseok Kang, MD",{"facility":120,"status":27,"city":121,"state":77,"zip":122,"country":58,"countryCode":59,"cosmosGeoPoint":123,"geoPoint":127,"contacts":128},"Moores Cancer Center","San Diego","92037",{"type":61,"coordinates":124},[125,126],-117.16472,32.71571,{"lat":126,"lon":125},[129,131],{"name":86,"role":69,"phone":130,"phoneExt":27,"email":88},"+1-858-534-5555",{"name":132,"role":44,"phone":27,"phoneExt":27,"email":27},"Assuntina Sacco, MD",{"facility":134,"status":27,"city":135,"state":77,"zip":136,"country":58,"countryCode":59,"cosmosGeoPoint":137,"geoPoint":141,"contacts":142},"UCSF Head and Neck Surgery Cancer Program","San Francisco","94158",{"type":61,"coordinates":138},[139,140],-122.41942,37.77493,{"lat":140,"lon":139},[143,146],{"name":86,"role":69,"phone":144,"phoneExt":27,"email":145},"+1-(415)-476-7119","clincal@corbuspharma.com",{"name":147,"role":44,"phone":27,"phoneExt":27,"email":27},"Alain Algazi, MD",{"facility":149,"status":27,"city":150,"state":151,"zip":152,"country":58,"countryCode":59,"cosmosGeoPoint":153,"geoPoint":157,"contacts":158},"UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado","Aurora","Colorado","80045",{"type":61,"coordinates":154},[155,156],-104.83192,39.72943,{"lat":156,"lon":155},[159],{"name":160,"role":44,"phone":27,"phoneExt":27,"email":27},"Antonio Jimeno, MD",{"facility":162,"status":27,"city":163,"state":164,"zip":165,"country":58,"countryCode":59,"cosmosGeoPoint":27,"geoPoint":27,"contacts":166},"Yale School of Medicine","Newhaven","Connecticut","06510",[167,171],{"name":168,"role":69,"phone":169,"phoneExt":27,"email":170},"Manager. Clinical Research Team for Head and Neck Cancer","+1-(474)-331-5081","sharon.huie@yale.edu",{"name":172,"role":44,"phone":27,"phoneExt":27,"email":27},"Aarti Bhatia, MD",{"facility":174,"status":27,"city":175,"state":176,"zip":177,"country":58,"countryCode":59,"cosmosGeoPoint":178,"geoPoint":182,"contacts":183},"Florida Cancer Specialists and Research Institute","Orlando","Florida","32827",{"type":61,"coordinates":179},[180,181],-81.37924,28.53834,{"lat":181,"lon":180},[184,186],{"name":86,"role":69,"phone":185,"phoneExt":27,"email":27},"+1 (407) 735-5695",{"name":187,"role":44,"phone":27,"phoneExt":27,"email":27},"Cesar Perez, MD",{"facility":189,"status":27,"city":190,"state":176,"zip":191,"country":58,"countryCode":59,"cosmosGeoPoint":192,"geoPoint":196,"contacts":197},"Moffitt Cancer Center Magnolia Campus","Tampa","33612",{"type":61,"coordinates":193},[194,195],-82.45843,27.94752,{"lat":195,"lon":194},[198,200],{"name":68,"role":69,"phone":199,"phoneExt":27,"email":88},"+1-(844)-608-4821",{"name":201,"role":44,"phone":27,"phoneExt":27,"email":27},"Guilherme Rabinowits, MD",{"facility":50,"status":27,"city":203,"state":204,"zip":205,"country":58,"countryCode":59,"cosmosGeoPoint":206,"geoPoint":210,"contacts":211},"Chicago","Illinois","60637",{"type":61,"coordinates":207},[208,209],-87.65005,41.85003,{"lat":209,"lon":208},[212,214],{"name":86,"role":69,"phone":213,"phoneExt":27,"email":88},"+1(855) 403-0529",{"name":49,"role":44,"phone":27,"phoneExt":27,"email":27},{"facility":216,"status":27,"city":217,"state":218,"zip":219,"country":58,"countryCode":59,"cosmosGeoPoint":220,"geoPoint":224,"contacts":225},"Iowa Health Care Holden Comprehensive Cancer Center","Iowa City","Iowa","52242",{"type":61,"coordinates":221},[222,223],-91.53017,41.66113,{"lat":223,"lon":222},[226,228],{"name":86,"role":69,"phone":227,"phoneExt":27,"email":88},"+1-319-356-4200",{"name":229,"role":44,"phone":27,"phoneExt":27,"email":27},"Douglas Laux, MD",{"facility":231,"status":27,"city":232,"state":233,"zip":234,"country":58,"countryCode":59,"cosmosGeoPoint":235,"geoPoint":239,"contacts":240},"Greater Baltimore Medical Center","Baltimore","Maryland","21204",{"type":61,"coordinates":236},[237,238],-76.61219,39.29038,{"lat":238,"lon":237},[241,244],{"name":242,"role":69,"phone":243,"phoneExt":27,"email":88},"Ian Clinical Study Coordinator","+1 (443)-849-2540",{"name":245,"role":44,"phone":27,"phoneExt":27,"email":27},"Geoffrey Neuner, MD",{"facility":247,"status":27,"city":248,"state":249,"zip":250,"country":58,"countryCode":59,"cosmosGeoPoint":251,"geoPoint":255,"contacts":256},"Dana Faber Cancer Institute","Boston","Massachusetts","02215",{"type":61,"coordinates":252},[253,254],-71.05977,42.35843,{"lat":254,"lon":253},[257,259],{"name":86,"role":69,"phone":258,"phoneExt":27,"email":88},"+1(877)-338-7425",{"name":260,"role":44,"phone":27,"phoneExt":27,"email":27},"Michael Dennis, MD",{"facility":262,"status":27,"city":263,"state":264,"zip":265,"country":58,"countryCode":59,"cosmosGeoPoint":266,"geoPoint":270,"contacts":271},"Barbara Ann Karmanos Cancer Institute - Wayne State University","Detroit","Michigan","48201",{"type":61,"coordinates":267},[268,269],-83.04575,42.33143,{"lat":269,"lon":268},[272,274],{"name":68,"role":69,"phone":273,"phoneExt":27,"email":27},"+1-(800)-537-6277",{"name":275,"role":44,"phone":27,"phoneExt":27,"email":27},"Ammar Sukari",{"facility":277,"status":27,"city":278,"state":279,"zip":280,"country":58,"countryCode":59,"cosmosGeoPoint":281,"geoPoint":285,"contacts":286},"Mayo Clinic in Rochester","Rochester","Minnesota","55059",{"type":61,"coordinates":282},[283,284],-92.4699,44.02163,{"lat":284,"lon":283},[287,289],{"name":86,"role":69,"phone":288,"phoneExt":27,"email":88},"+1 (855) 776-0015",{"name":290,"role":44,"phone":27,"phoneExt":27,"email":27},"Katharine Price, MD",{"facility":292,"status":27,"city":293,"state":294,"zip":295,"country":58,"countryCode":59,"cosmosGeoPoint":296,"geoPoint":300,"contacts":301},"Nebraska Cancer Specialists - Methodist Estabrook Cancer Center","Omaha","Nebraska","68130",{"type":61,"coordinates":297},[298,299],-95.94043,41.25626,{"lat":299,"lon":298},[302,304],{"name":68,"role":69,"phone":303,"phoneExt":27,"email":88},"+1-(402)-717-4770",{"name":305,"role":44,"phone":27,"phoneExt":27,"email":27},"Yungpo Su, MD",{"facility":307,"status":27,"city":308,"state":308,"zip":309,"country":58,"countryCode":59,"cosmosGeoPoint":310,"geoPoint":314,"contacts":315},"Memorial Sloan Kettering","New York","10021",{"type":61,"coordinates":311},[312,313],-74.00597,40.71427,{"lat":313,"lon":312},[316,318],{"name":68,"role":69,"phone":317,"phoneExt":27,"email":88},"+1-(332)-378-0413",{"name":319,"role":44,"phone":27,"phoneExt":27,"email":27},"Alan Ho, MD",{"facility":321,"status":27,"city":322,"state":323,"zip":324,"country":58,"countryCode":59,"cosmosGeoPoint":325,"geoPoint":329,"contacts":330},"Grabrail Cancer Center and Research Center","Canton","Ohio","44718",{"type":61,"coordinates":326},[327,328],-81.37845,40.79895,{"lat":328,"lon":327},[331,333],{"name":68,"role":69,"phone":332,"phoneExt":27,"email":27},"+1-(330)-492-3345",{"name":334,"role":44,"phone":27,"phoneExt":27,"email":27},"Nashat Gabrail, MD",{"facility":336,"status":27,"city":337,"state":338,"zip":339,"country":58,"countryCode":59,"cosmosGeoPoint":340,"geoPoint":344,"contacts":345},"Penn-Medicine - Abramson Cancer Center University of Pennsylvania","Philadelphia","Pennsylvania","19104",{"type":61,"coordinates":341},[342,343],-75.16362,39.95238,{"lat":343,"lon":342},[346,348],{"name":86,"role":69,"phone":347,"phoneExt":27,"email":88},"+1-(800)-789-7366",{"name":349,"role":44,"phone":27,"phoneExt":27,"email":27},"Lova Sun, MD",{"facility":351,"status":27,"city":337,"state":338,"zip":352,"country":58,"countryCode":59,"cosmosGeoPoint":353,"geoPoint":355,"contacts":356},"Fox Chase Cancer Center","19111",{"type":61,"coordinates":354},[342,343],{"lat":343,"lon":342},[357,359],{"name":68,"role":69,"phone":358,"phoneExt":27,"email":88},"+1-(844)-669-0274",{"name":360,"role":44,"phone":27,"phoneExt":27,"email":27},"Parth Desai, MD",{"facility":362,"status":27,"city":363,"state":364,"zip":365,"country":58,"countryCode":59,"cosmosGeoPoint":366,"geoPoint":370,"contacts":371},"Prisma Health Cancer Institute Multidisciplinary Center","Greenville","South Carolina","29605",{"type":61,"coordinates":367},[368,369],-82.39401,34.85262,{"lat":369,"lon":368},[372,374],{"name":68,"role":69,"phone":373,"phoneExt":27,"email":88},"+1-(864)-455-7000",{"name":375,"role":44,"phone":27,"phoneExt":27,"email":27},"Richard O'Neal, MD",{"facility":377,"status":27,"city":378,"state":379,"zip":380,"country":58,"countryCode":59,"cosmosGeoPoint":381,"geoPoint":385,"contacts":386},"UVA Health - Emily Couric Clinical Cancer Center","Charlottesville","Virginia","22908",{"type":61,"coordinates":382},[383,384],-78.47668,38.02931,{"lat":384,"lon":383},[387,388],{"name":68,"role":69,"phone":27,"phoneExt":27,"email":88},{"name":389,"role":44,"phone":27,"phoneExt":27,"email":27},"Varinder Kaur, MD",{"facility":391,"status":27,"city":392,"state":393,"zip":394,"country":58,"countryCode":59,"cosmosGeoPoint":395,"geoPoint":399,"contacts":400},"Fred Hutchinson Cancer Center Clinical - Seattle Cancer Care Alliance","Seattle","Washington","98109-1024",{"type":61,"coordinates":396},[397,398],-122.33207,47.60621,{"lat":398,"lon":397},[401,403],{"name":86,"role":69,"phone":402,"phoneExt":27,"email":88},"+1-(800).422.6237",{"name":404,"role":44,"phone":27,"phoneExt":27,"email":27},"Lauren Shih, MD",{"facility":406,"status":27,"city":407,"state":393,"zip":408,"country":58,"countryCode":59,"cosmosGeoPoint":409,"geoPoint":413,"contacts":414},"Northwest Cancer Center","Vancouver","98684",{"type":61,"coordinates":410},[411,412],-122.66149,45.63873,{"lat":412,"lon":411},[415,417],{"name":68,"role":69,"phone":416,"phoneExt":27,"email":88},"+1-(360)-449-6521",{"name":418,"role":44,"phone":27,"phoneExt":27,"email":27},"Tristan Bice",{"facility":420,"status":27,"city":421,"state":422,"zip":423,"country":424,"countryCode":425,"cosmosGeoPoint":426,"geoPoint":430,"contacts":431},"University Hospital Vienna","Vienna","State of Vienna","1090","Austria","AT",{"type":61,"coordinates":427},[428,429],16.37208,48.20849,{"lat":429,"lon":428},[432,434],{"name":68,"role":69,"phone":433,"phoneExt":27,"email":88},"+43 (0)1 40400-39400",{"name":435,"role":44,"phone":27,"phoneExt":27,"email":27},"Thorsten Fuereder",{"facility":437,"status":27,"city":438,"state":438,"zip":439,"country":440,"countryCode":441,"cosmosGeoPoint":442,"geoPoint":446,"contacts":447},"Barts Health NHS Trust","London","E1 1RD","United Kingdom","UK",{"type":61,"coordinates":443},[444,445],-0.12574,51.50853,{"lat":445,"lon":444},[448,451],{"name":68,"role":69,"phone":449,"phoneExt":27,"email":450},"+44 (020) 7882 5555","bartshealth.ecmc@nhs.net",{"name":452,"role":44,"phone":27,"phoneExt":27,"email":27},"Pablo Nenclades, MD",{"type":454,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR",[456],{"name":457,"class":6},"CSPC Megalith Biopharmaceutical Co.,Ltd.","100652056","phase-3-a-randomized-multicentre-study-to-evaluate-crb-701-compared-to-investigators-choice-therapy-in-previously-treated-oropharyngeal-squamous-cell-carcinoma-100652056",false,"NCT07768189","A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma","A Randomized, 2-Arm Study to Evaluate the Efficacy and Safety of CRB-701 Compared With Investigator's Choice of Capecitabine, Cetuximab, or Docetaxel in Participants With Recurrent or Metastatic Oropharyngeal Squamous Cell Carcinoma Previously Treated With Platinum-based Chemotherapy and a PD-(L)1 Inhibitor","TEMPO-1","Inclusion Criteria:\n\n* Histological and\u002For cytological confirmed diagnosis of OPSCC arising from tonsils, base of tongue, soft palate and posterior pharyngeal wall, with evidence of metastatic or recurrent disease not amenable to standard therapy with curative intent.\n* Either second or third-line OPSCC patients who have progressed on or after receiving SOC therapy (that must have included platinum chemotherapy and an anti-PD-(L)1 antibody administered sequentially or together) OR received platinum chemotherapy and\u002For anti-PD-(L)1 therapy in the neoadjuvant or adjuvant setting or as part of definitive chemoradiation therapy, provided disease recurrence occurred less than 6 months after completion of the relevant systemic therapy.\n* ECOG PS of 0-1\n* Measurable disease as per RECIST v1.1, with at least one measurable lesion not previously irradiated unless unequivocal progression has been documented after radiation.\n* Life expectancy of greater than 12 weeks at time of enrollment, as per Investigator's assessment.\n\nSigned informed consent\n\nExclusion Criteria:\n\n* Persistent CTCAE Grade \\>1 clinically significant toxicities related to prior antineoplastic therapies, excluding alopecia.\n* Significant active or chronic corneal disorders\n* Pre-existing Grade ≥2 peripheral neuropathy\n* Any other significant co-morbidities, disease, metabolic dysfunction, physical examination, or clinical laboratory finding that contraindicates the use of the investigational drug or may represent an unacceptable risk from treatment complications or may affect adherence to the study procedures or the interpretation of the results.\n* Pregnant or breastfeeding females","ALL","18 Years",{"count":469,"type":470},260,"ESTIMATED","INTERVENTIONAL",[473],"PHASE3","The goal of this study is to understand whether CRB-701, a targeted form of chemotherapy called an anti-body drug conjugate, will work as a treatment for oropharyngeal (throat, tonsil) cancer. In patients who have already received platinum based chemotherapy or immunotherapy (using a check-point inhibitor) It will also learn about the safety of the drug and measure quality of life. The main questions it asks are:\n\n* What proportion of participants respond to CRB-701 measured using scans (CT or MRI)\n* What medical problems do participants experience when taking CRB-701.\n\nResearchers will compare CRB-701 with standard of care medicines (drugs that are normally used this disease).\n\nParticipants will:\n\n* Attend clinic every three weeks to receive infusions of CRB-701 or standard of care medicines until the cancer cannot be measured or is not controlled by the treatment they are receiving.\n* Have a CT or MRI every 6 weeks to measure the effect on their cancer\n* Complete questionnaires to assess their health status.",[476],"Oropharyngeal Carcinoma (OPC)",[478,479,480,481,482,483],"Antibody Drug Conjugate","Nectin-4","Oropharyngeal Squamous Cell Carcinoma","HPV-ve","HPV+ve","Head and Neck Squamous Cell Carcinoma","NOT_YET_RECRUITING","2026-08-18",{"date":487,"type":488},"2026-08-20","ACTUAL",{"date":490,"type":470},"2026-09-20",{"date":492,"type":470},"2029-03",{"name":5,"class":6},27]